University of New Mexico

UNM Digital Repository
Chemical and Biological Engineering ETDs

Engineering ETDs

7-11-2013

DEVELOPMENT OF SURFACE BASED
PLATFORMS FOR BIOMOLECULAR
RECOGNITION AND PROTEASE ASSAYS
Jose Cornejo

Follow this and additional works at: https://digitalrepository.unm.edu/cbe_etds
Recommended Citation
Cornejo, Jose. "DEVELOPMENT OF SURFACE BASED PLATFORMS FOR BIOMOLECULAR RECOGNITION AND
PROTEASE ASSAYS." (2013). https://digitalrepository.unm.edu/cbe_etds/41

This Thesis is brought to you for free and open access by the Engineering ETDs at UNM Digital Repository. It has been accepted for inclusion in
Chemical and Biological Engineering ETDs by an authorized administrator of UNM Digital Repository. For more information, please contact
disc@unm.edu.

Jose Alberto Cornejo
Candidate

Chemical And Nuclear Engineering
Department

This thesis is approved, and it is acceptable in quality and form for publication:
Approved by the Thesis Committee:
Dr. Steven Graves, Chairperson
Dr. James Freyer
Dr. Andrew Shreve

DEVELOPMENT OF SURFACE BASED PLATFORMS FOR
BIOMOLECULAR RECOGNITION AND PROTEASE ASSAYS

By

JOSE A. CORNEJO
B.S., CHEMICAL ENGINEERING, 2009
M.S., CHEMICAL ENGINEERING, 2013

THESIS
Submitted in Partial Fulfillment of the
Requirements for the Degree of
Master of Science
Chemical Engineering
The University of New Mexico
Albuquerque, New Mexico
May 2013

Dedication

ii

This thesis is dedicated to my loving wife Vicki for her for all her
love, support, and for her infinite patience in the process of
building this thesis. And to my parents and sisters for all their love
and encouraging words

iii

ACKNOWLEDGEMENTS
I would like to express my appreciation to the members of my committee of
studies: Dr. Steven Graves (advisor and chair), Dr. James Freyer, and Dr. Andrew
Shreve. Thank you for your constant support and instruction. Your unconditional
mentorship and efforts to push me towards excellence in research practices will resonate
in my future endeavors. Thank you Dr. Graves for all of your support, for pushing
towards excellence at all times, you have played a crucial part in my professional
development. I would like to extend my appreciation to Dr. Gabriel Lopez for his
mentorship, support and for introducing me to biomedical engineering research. This has
truly been a positive learning experience that has made me a better researcher. Thank you
all for your professional guidance.
This study was in part funded by the National Science Foundation’s Partnership
for Research and Education in Materials (PREM), the National Institutes of Health’s
Initiative for Maximizing Student Development (IMSD), and the National Flow
Cytometry Resource.
I would like to acknowledge everyone that has helped me through this process.
Dr. Linnea Ista, Dr. Menake Piyasena, Dr.Nesia Zurek, Carl Brown III, Kevin Cushing,
Andrew Goumas, Matthew Rush, Travis Woods, Jingshu Zhu, and Michael Zubelewicz
thank you for your thoughtful inputs and relevant discussions directly related to this
study.
Additional thanks to Dr. Margaret Werner-Washburne for all her encouraging
words that have helped me grow professionally and personally. To Dr. Menake Piyasena
for all his training, immediate supervision, and for requiring my best at all times. Travis
iv

Woods for all his uncompensated time instructing me in instrumentation usage, all his
technical training, and his willingness to help with any technical issues in the laboratory.
To all the wonderful people that make up the Center for Biomedical Engineering for
making this a positive, fun, and very productive environment.

v

Development of Surface Based Platforms for Biomolecular Recognition
and Protease Assays
By
Jose A. Cornejo
B.S., Chemical Engineering, University of New Mexico, 2009
M.S., Chemical Engineering, University of New Mexico, 2013

ABSTRACT
The discovery of analytical tools for biomolecular recognition in the area of diagnostics
is a research trend rich in innovative methods. Some of the main drivers found in this
area are the constant need for low cost devices and biosensors, simplicity in design and
operation, and time efficiency. In this thesis we present novel approaches for the
development of protease activity assays. Our focus of study is the protease assay
development process on two types of characterized platforms: microspheres and selfassembled monolayers (SAMs) on flat surfaces. The surface preparation and conjugation
process with biological components of interest is presented along with surface plasmon
resonance (SPR) and flow cytometry results.
These platforms were engineered in order to develop assays for bacterial toxin
activity. Bacterial toxins are comprised in part of proteases, which selectively cleave
peptides bonds in proteins. In this thesis we present, protease assays from our main focus
of studies, the Clostridium botulinum Neurotoxin type A Light Chain (BoNTA/LC)
metalloprotease. Supplementary studies include assays performed involving the Bacillus
anthracis Lethal factor metalloprotease. In the work described we have prepared active
vi

recombinant protease substrates in our laboratory, capable of binding with the surfaces of
study. In addition, we present methods to on how to address non-specific binding issues
inherited by the nature of these assays. Commercially available recombinant proteases
have been utilized throughout these studies. These studies present novel methods for
BoNT protease detection based on previous microsphere-based assays. Our biomimetic
detection platforms show promise for further understanding BoNTs toxicity, the
biological pathways of BoNTs substrates, and possible contributions to the discovery of
protease inhibitors.
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Chapter 1
Introduction
1.1 Current Protease Studies in Flow Cytometry
Flow cytometry is a technique capable of analyzing information in individual cells as
well as in microspheres. This is why flow cytometry has been utilized extensively in the
studies of microsphere as molecular carriers for the development of a wide variety of
assays1,2. Furthermore, advances in flow cytometry feature multiplexible bead-based
assays for high throughput screening and drug discovery3. As a result, flow cytometry has
been utilized for the studies of multiplexible Botulinum neurotoxin (BoNT) protease
assays and high throughput screening for drug targeting4,5. Adequate assays require
proper bio-conjugation of microspheres for the analysis of substrate/protease interactions
at their surfaces. Based on these studies, we have incorporated recombinant protein
technologies, surface preparation, and protease assay development to our designs and
applications of novel methodologies for BoNT protease activity detection.

1.2 Background Information on the BoNT Proteases and their Substrates
Muscle contraction, a very important feature in humans, is the result of interactions
between muscle cells and neurons. Major contributors for these interactions are the
Soluble N-ethylmaleimide Sensitive Fusion Attachment Protein Receptors (SNAREs).
These proteins are located inside neurons and act together in order to anchor synaptic
vesicles with the neuron’s outer membrane6. This anchoring effect enables the release of
the neurotransmitter acetylcholine outside of the neuron and the subsequent binding to
1

acetylcholine receptors at the muscle cell’s membrane. Along with subsequent reaction
steps, these reaction pathways are in charge of assuring a normally functioning nervous
system. Botulinum neurotoxins high toxicity is due to their ability to directly interfere
with neurotransmitter release, thus causing muscle paralysis and death7. There are seven
BoNT serotypes known to target SNARE proteins and specifically cleave them8. The
SNARE protein complex is comprised of synaptobrevin, syntaxin and synaptosomalassociated protein 25 (SNAP-25), which is covered in this thesis.

1.3 Novel Approaches for Protease Activity Assays
In chapter 2 we introduce the use of gold-coated surfaces containing self-assembled
monolayers (SAMs) as surface plasmon resonance (SPR) biosensors. Due to the facility
provided by SPR to perform protein adsorption on SAMs9, we present protease activity
assays tailored for SPR analysis. BoNT proteases follow a single-substrate mechanism of
enzymatic reaction10. Therefore, SPR allows one to differentiate in real time between
BoNTA/LC substrate binding and catalytic events (substrate cleavage). Adequate protein
adsorption methods are crucial for the success of these assays. As such, we have taken
into account a significant amount of information from publications reporting proper
recombinant protein expression and purification techniques. Substrate plasmids were
based on Promega PinPoint biotinylation tag vectors due to their abundance and
availability in our laboratory. This approach, coupled with avidin resin filtration matrices,
is known to yield high levels of soluble biotinylated proteins11. Taking this technology
into consideration along with previous binding studies12, we present fabricated
biotinylated SPR sensor chips for the immobilization of streptavidin that allow the
binding of succeeding biotinylated proteins.
2

In chapter 3 we explore the advantages of packed bed microfluidic channels for
protease activity analysis. In them, we analyze sequestered streptavidin bearing
microspheres to be coupled with our prepared biotinylated substrate proteins containing
GFP markers. Packed beads in microchannels provide a high surface area to volume
ratio, thus reducing analyte diffusions distances13 and providing high sensitivity in the
limits of protease detection. Here, we show how fluorescence-based protease assays are
tailored for the use of fluorescence microscopy and fluorimetry.
In chapter 4 we present the utility of supported lipid bilayers on silica microspheres as
biomimetic platforms for BoNT protease detection. It is suggested that membrane
proteins

interact

with

these

biomimetic

platforms

while

maintaining

their

functionality14,15. Therefore, our efforts have been focused on the design of supported
lipid bilayers (SLBs) on microspheres capable of mimicking protein interactions with the
neuron’s plasma membrane. Taking into consideration the palmitoylation process, which
will be explained in chapter 4, we have explored several types of lipids with moieties
capable of forming selective bonds with thiol group from cysteines residues found in
SNAP-2516. As a result, our studies also address ways of minimizing non-specific
binding throughout the process development of protease assays using flow cytometry.
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Chapter 2
Surface-based Protease Assays for Surface Plasmon Resonance Analysis
2.1 Introduction
2.1.1 Surface Plasmon Resonance Background Information
Surface plasmon resonance (SPR) is a physical phenomenon that is originated by the
reflection of incident laser light (this is the case of the SPR instruments presented in this
work) upon a thin metal film. Surface plasmons are oscillations of free electrons, that
when excited into resonance by applying such light source, the incident light is absorbed
by the metal film triggering a low intensity reflection1 (see figure 2-1). During this
resonance event, and with the aid of a material with a high refractive index such as a
prism, one can formulate a relationship between the dielectric constants of the metal film
(e.g. gold-coated film) and the testing medium (e.g. proteins in buffer solution) to the
angle of light incident onto the metal film. Such relationship is expressed by equation 21:

sin(Θ R ) =

ε1ε m
(ε1 + ε m )ε 2

eq. 2-1

Where ε1 is the dielectric constant of the testing medium, ε2 is the dielectric constant
of the prism and εm is that of the exposed sensor metal film. Our SPR instrumentation is
designed following the Kretschmann configuration, where the light source is located on
the glass side of the thin film, which is the opposite side of the metallic layer. As

6

molecules reach the metal surface the local index of refraction changes, thus shifting the
resonance angle. This phenomenon makes SPR a high detection sensitivity method and a
label-free technique for the immobilization of biomolecules.

A%

Flow%cell%

Gold%layer%

Glass%side%
%%Reﬂected%light%
%
SPR%angle%

Prism%

Laser%(incident%light)%

B$

SPR$angular$shi.$
Figure 2-1. The Kretschmann SPR configuration. (A) The light source is located on the opposite
side of the metallic layer, that is, the glass side. (B) A plasmon is an electron charge density wave
at the metal film that is excited by the incident light due to its energy and angle of incidence.
Absorption of energy occurs causing surface plasmons. This phenomenon is described by the
decrease in reflected light intensity as a function of the angle of reflection (SPR angle is located
at the minimum).
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2.1.2 SPR Sensor Chips for Protease Detection Assays
SPR studies described in this work consist of gold-covered thin films because of the
metal’s small real refraction index and large imaginary refraction index for the
wavelengths of optical excitation2. Because of these physical properties, gold is presented
as a suitable candidate for biosensor nanotechnology and therefore, a suitable substrate
for SPR studies. In addition, it is known that gold binds thiols with high affinity3,
providing high SAM stability for several days if in contact with a liquid medium.
Functionalized thiols were used as the building backbones for all SPR chips. Their
fabrication process consists of two steps. First, the surface of thin glass cover slips is
modified by thermal vapor gold deposition. Second, self-assembled monolayers (SAMs)
are formed on the surface of the gold-treated thin films by submersion in ethanol
solutions containing biotin-functionalized thiols. We followed this methodology because
it was crucial to alleviate biosensor costs. Protease assays on commercially available
functionalized SPR biosensors specifically designed for biotinylated protein capturing
present elevated costs due to surface regeneration issues. As a result, we present a less
expensive alternative consisting of formed SAMs specifically designed for streptavidin
immobilization and further interactions with biotinylated receptors. In addition, we had
several components readily available in our laboratory for the fabrication of SAMs such
as gold and a metal evaporator for gold deposition.
As mentioned in the previous section, SPR allows us to measure bound analyte on
biosensors using a label-free type of detection, in real time. Therefore, we implemented
the development of BoNT protease assay to this approach in order to monitor the
molecular interactions between substrate and protease. The compounds of interest in our

8

SPR studies included proteases from Botulinum neurotoxins and anthrax lethal toxins.
Such proteases interact with their respective substrates (host proteins) by cleaving them at
specific sites4, 5. The importance of this work lays on the increasing interest of the study
of such proteases due to their role in natural disease6, their potential use in bioterrorism6,
and therefore the exploration for approaches to recognize effective inhibitors. This
chapter is devoted to the exploration of activity and detection assays related to these
components. We hypothesized that given successful binding of streptavidin and SNAP25 biotinylated substrate to a sensor chip, we could be able to monitor for specific
activity of the BoNTA/LC protease and study important parameters such as reaction
times and amount of mass bound or dissociated from the sensor surface at all times by
using SPR.

S"""S"""S"

S"""S"""S"

Response'Units'

S"""S"""S"

S"""S"""S"

*'
+me''

Figure 2-2. Hypothetical sensorgram for protease detection and activity assays. The first binding
curve represents the binding of streptavidin to biotinylated SAMs at the SPR chip surface. The
second binding curve corresponds to biotinylated protease substrate binding to the streptavidinrich SPR chip. The third bind curve represents the initial binding of a protease to its specific
substrate, and subsequent cleavage. *The cleavage effect and any other binding events will be
quantified by the calculation of amount of mass gained or lost at the surface of the SPR chip by
monitoring the change in response units at the given reference points. Thus, a decrease in
response units will be expected at the end of an experimental run.
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2.2 Materials and Methods
2.2.1 SAMs Formation and Development of SPR Sensor Chips
SAMs were prepared as previously described7, 8. Microscope cover slips were
prepared by immersing them in piranha solution

(30% H2O2 and 70% H2SO4.

CAUTION: piranha solution reacts violently with most organic materials thus causing
burns to the skin. It must be handled with extreme care in a certified safety hood with
fully personal protective equipment. They were then rinsed with DI water and absolute
grade ethanol and dried by a nitrogen stream prior to being placed in a vacuum chamber
to begin the gold-coating process. The coating process was done by thermal evaporation
deposition of 2nm of chromium and 50 nm of gold 99,999% in purity (Plasmaterials,
Livermore, CA). For the formation of SAMs, the freshly gold-coated cover slips were
submerged for a minimum of 16 hours in a solution containing 1 mM biotin-terminated
tri-(ethylene glycol) undecanethiol (Asemblon, Seattle, WA) in ethanol (200 proof, Fisher
Scientific, Waltham, MA). When ready for experimentation, the SAMs were rinsed with
ethanol and dried under nitrogen.

2.2.2 Surface Characterization
Once the biotin-terminated SAMs were formed, they were analyzed by surface
wettability measurements. Contact angles from water drops on the SAMs were measured
using a Ramé-Hart Model 100 goniometer (Succasunna, NJ). Drops were placed on three
different regions randomly selected and an average of 3 angle measurements per drop
was acquired. These measurements allowed us to measure the hydrophobicity of the

10

biotin-containing SAMs and to corroborate with previous wettability calculations on
identical surfaces reported in the literature.
2.2.3 Construction of biotinylated substrate SNAP-25 GFP plasmids
SNAP-25 GFP protease substrate plasmids were based on the Promega PinPoint
technology9. These vectors featured a biotinylation tag at the N terminus and enhanced
green fluorescence protein (EGFP) cloned at the C terminus. The SNAP-25 GFP
expression plasmid was produced by restriction digest of the Xa sub-plasmid and ligation
of a SNAP-25 PCR product that was obtained from a SNAP-25 clone plasmid.
Transformation of these plasmid ligations was performed in competent BL21 (DE3) pLys
S E. coli by following the miniprep method (Qiagen).

2.2.4 Expression and Purification of SNAP-25 GFP Protease Substrate
Transformation of BL21 (DE3) pLys S E. coli calcium competent cells was
performed as previously described10. Briefly, transformed bacterial cells with SNAP-25
GFP plasmid were grown overnight at 37°C in 3 mL of TB media with the addition of 50
µg/mL of carbenicillin and 34 µg/mL chloramphenecol in order to enable antibiotic
resistance. They were then transferred to 250 mL of TB containing 50 µg/mL of
carbenicillin, 34 µg/mL chloramphenicol, and 40 µM biotin. Incubation followed until
the cultures reached an optical density at wavelength 600 nm between 0.6 and 0.8.
Cultures were then induced with 100 µM Isopropyl β-D-1-thiogalactopyranoside (IPTG,
Life Technologies) and grown at 30°C overnight. Cells were spun down at 4000 rpm for
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30 min on a centrifuge at 4°C, suspended in lysis buffer (50 mM Tris–HCl, 1mM
ethylenediaminetetraacetic acid (EDTA), 100 mM NaCl, pH 8.3), and frozen at −20°C.
Once ready for protein purification, frozen cells were thawed on ice, sonicated for
10 min, and centrifuged at 4°C at 14000 rpm for 30 min. The soluble fraction was loaded
onto a Fast protein liquid chromatography (FPLC, GE Healthcare) containing 5mL of
Softlink streptavidin resin (Promega). The product was eluted using 1mM dithiothreitol
(DTT), 5 mM biotin in phosphate buffer saline (PBS). The fractions were centrifuged in
an Amicon Ultra-15 30,000 molecular weight cutoff filter for 10 min at 4,000 rpm at 4°C
in order to remove free biotin and thus, reduce non-specific binding affecting the protease
assays. The purified protein was then dialyzed for 3 rounds against 3 L of 50 mM
HEPES, 100 mM NaCl, pH 7.4 for 4 hours each round. Final protein was determined
using A280 spectroscopic measurements given that the extinction coefficient for
biotinylated SNAP-25 GFP was calculated to be 28,740 cm-1M-1.

2.2.5 Binding SNAP-25 GFP Substrate to SPR Senor Chips
Gold-coated sensor chips containing thiolated SAMs were docked to surface
plasmon resonance instrument (Biacore X100, GE Healthcare) which was primed by
running buffer consisting of 50 mM HEPES, 100 mM NaCl, 1 mg/mL BSA, 0.025%
Tween 20, pH 7.4 through the instrument’s flow cell. Once a stable baseline was
achieved (see Fig?), streptavidin at concentrations ranging from 0.1 to 1 µM was injected
at a flow rate of 10 µL/min for 10 minutes. This was followed by the injection of
biotinylated SNAP-25 GFP substrate at concentrations ranging from 100 nM to 500 nM.

12
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Figure 2-3. SPR sensor chip development. A) Self-assembled monolayers consisting of
biotinylated alkyl thiols (BATs) attached to a gold-covered coverslip after being submerged in
ethanol solution containing 1 mM BAT. Thus, the surface was made compatible to be used as a
sensor chip for surface plasmon resonance instruments. B) Once introduced to the SPR
instrument, streptavidin was injected at different concentrations in order to specifically bind to the
biotin receptors at the SAMs by using its first pair of binding pockets. C) Upon streptavidin
immobilization, a biotinylated substrate protein is introduced to bind to the second binding pairs
from each streptavidin molecule.

Recombinant Botulinum neurotoxins type A and type F light chain proteases and
Anthrax Lethal Factor protease were obtained from List Biological Laboratories
(Campbell, CA). Each protease vial was resuspended in protease buffer to a concentration
of 0.1 mg/mL.
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2.3 Results
2.3.1 Surface Characterization
Surface analysis of the SAMs was performed by contact angle measurements by
determining the degree of hydrophobicity of the surface in question. Biotin-terminated
SAMs presented a water contact angle of 49 +/- 1O. Previous wettability studies on an
identically prepared surface reported a water contact angle of 55+/- 3O. 8As expected the
bare gold surface presented a more hydrophobic environment. This was used as a
reference point to verify that modification of gold substrates by using monolayers of
biotin-terminated tri-(ethylene glycol) undecanethiol creates a more hydrophilic surface.

90"

Contact'Angle'(Deg)'

80"
70"
60"
50"
40"
30"
20"
10"
0"
BAT"Sensor"Chip"

Literature"Sensor"
Chip"

Control"Au"

Figure 2-4. Surface characterization of SPR sensor chip by contact angle measurements. Blue: Contact
angle of biotinylated SAM used as SPR sensor chips in protease assays. Orange: Contact angle from
identical biotinylated alkyl thiol SAM reported in the literature.8 Yellow: Contact angle of bare goldcovered surface.
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2.3.2 Binding Assays Analysis
Figure 2-4 presents the components of a commercial SPR instrument. Buffer
present in reservoir (A) and the injecting sample rack (B) are mixed at the flow cell
platform (C) right before molecular recognition by SPR.

B

C

B

A

C

D

Figure 2-5. Components of a commercial SPR system. GE Biacore (left) and Biosensing
Instrument (right). (A) Buffer reservoir. (not pictured in BI system) (B) Sample collection deck.
In the case of BI system, each sample is injected with a Hamilton syringe at the sample port. (C)
Optics region. Buffer and samples arrive to this platform through the instrument’s tubing system
at laminar flow. There, a flow cell transports them to the SAMs-rich gold surface. In the BI SPR
system, buffer reservoir is not pictures (D) Waste reservoir.

At the start of every run, buffer was first introduced to the Biacore X-100 SPR
system as it traveled through the instrument’s tubing system at laminar flow and reached
the interrogation region composed of the SAMs-covered gold surface enclosed by the
instrument’s flow cell. Figure 2-6 shows a binding assay incorporating streptavidin and
SNAP-25 GFP starting with a steady baseline from the introduction of running buffer to
the system and finishing with the partial dissociation of SNAP-25 GFP from the surface
of the SPR chip.
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Figure 2-6. SPR sensorgram for surface protein immobilization. This sensorgram indicates the
amount of streptavidin and biotinylated SNAP-25 GFP bound to the sensor chip as a function of
time. One response unit (RU) is equivalent to 0.0001o of angular shift in the refractive index.

Figure 2-6 features a binding curve between biotinylated SNAP-25 and
streptavidin containing three different phases: the association phase (rise), the
equilibrium phase, and the dissociation phase (drop). These processes can be represented
by first-order bimolecular reaction expressed as follows:

ka

A + B ←#
→A− B
kd

eq. 2-2

where A represents streptavidin bound to the SPR chip, B represents SNAP-25 as sample
solution introduced into the flow cell of the system. The term ka is the association rate
constant and kd is the dissociation rate constant. Thus, the reaction rate can be monitored
by the SPR response (R) signal at time t:
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dR
= kaC(Rmax − R) − kd R
dt

eq. 2-3

where R is the SPR signal at time t, C is the concentration of SNAP-25 and Rmax is the
maximum signal response of SNAP-25 molecules bound to the sensor chip. Therefore,
we were able to quantify the amount of molecules that remain bound to the sensor surface
and the amount of molecules that dissociate from the surface sensor. Likewise, the
dissociation phase can be described by the following equation:

dR
= −kd R
dt

eq. 2-4

2.3.3 BoNTA/LC Protease Assay Analysis
After repeated successful binding assays such as the one presented in figure 2-6, we
proceeded to test this biosensing platform for BoNTA/LC protease activity. After
injection of the biological components previously described, BoNTA/LC protease was
injected at concentrations not exceeding 20 nM. All components were introduced at equal
volumes. It is important to state that the SPR computer program calculates the time of
sample injection, which is directly proportional to the volume of the sample that is being
analyzed. Therefore all samples were injected at equal times except for buffer washing
steps of smaller volumes containing a given amount of BSA in order to reduce nonspecific binding. Protease assays were performed within 10 days of opening our
commercial recombinant BoNTA/LC vial in order to prevent denaturation.
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Figure 2-7. BoNTA/LC protease assay I. (A-A’) Injection of streptavidin. (B-B’) Injection of
SNAP-25 GFP. (C-C’) BoNTA/LC protease injection. Observed decrease in response near the
end of the sensorgram is associated with presumed protease activity.

From these SPR sensorgrams, one can easily differentiate between the time it takes
for the protease to bind with its substrate and the time involved with the proteolytic
activity leading to cleavage of the substrate. Further experimentation shows a second
sensorgram (figure 2-8) showing both the substrate-binding step and the proteolytic step
triggering less pronounced changes in SPR response compared to those in figure 2-7.
While all components and concentrations were handled in a similar way as in the first
experiment, this run was performed at a later time. At the end of the experimental run we
observed a decrease in response of 251 RUs compared to the point right after the end of
the protease injection (approximately at the 1800-second mark). However, the observed
decrease in response did not reach the level corresponding to the SNAP25 substrate, thus
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showing no signs of cleavage (proteolytic activity). One explanation for lack of cleavage
in this instance can be attributed to the possibility of the protease undergoing protein
denaturation due to its high sensitivity to temperature changes and time after its
suspension in buffer.
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Figure 2-8. BoNTA/LC protease assay II. (A-A’) Streptavidin injection. (B-B’) SNAP-25 GFP
injection. (C-C’) injection BoNTA/LC protease sample. We monitored for protease cleavage by
comparing the completed BoNTA/LC protease injection time point (association step) to response
signal at the last recorded time point. Protease response shows near- complete dissociation after
the substrate-binding step. Response signal from proteolytic step showed a decrease of 94 RU.

Figure 2-8 presents the same scenario presented in figure 2-7. While we can
observe a decrease in response after protease injection, there is no cleavage associated
with this decrease because of the response ending above the recorded level after SNAP25 substrate injection.
2.3.4 Lethal Factor Protease Assay Analysis
A similar protease assay was performed for the detection of the anthrax toxin lethal
factor protease. We obtained the recombinant protease substrate for following the same
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expression and purification protocols described in section 2.2. This biotinylated substrate
contained the active cleavage regions for lethal factor protease and it was designated as
LF-15 GFP. Similar results were obtained showing unsuccessful protease cleavage by the
lethal factor protease although a decrease of 99 RUs was recorded.
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Figure 2-9. Lethal factor protease assay I. (A-A’) Injection of streptavidin. (B-B’) Injection of
LF-15 GFP substrate. (C-C’) Injection of lethal factor protease. Protease substrate-binding step
gave a response signal of 328 RU while the proteolytic step presented a decrease of 99 RU.

When an identical lethal factor protease assay was performed (figure 2-10) a more
pronounced decrease is appreciated, which reaches the level prior to SNAP-25 injection
Because of this, the detection of protease cleavage is still unclear. In addition, the
response signal following streptavidin injection seem is very similar to that following
protease injection. At first, they appear to be bound to the sensor surface after
dissociation response signals but then, further dissociation occurs. This leads to further
discussion on the specificity of protease cleavage, which will be covered in chapter 5.
20

37000
36000

A’#

Response (RU)

35000

D’#

C’#
B#

34000
33000

D

32000

C# ∆RU=#758#

31000
30000

A

∆RU=#217#
∆RU=#11113#

∆RU=#2238#

29000
0

500

1000

1500

2000

2500

3000

Time (s)

Figure 2-10. Lethal factor protease assay II. (A-A’) Injection of streptavidin. (B) Block injection
of 1 mg/mL BSA. (C-C’) Injection of LF-15 GFP substrate. (D-D’) Injection of lethal factor
protease. Apparent cleavage is seen by lethal factor proteolytic activity. Further analysis suggests
cleaving effect is non-specific due to similar decrease in response signal found after streptavidin
binding as well as in after protease binding.

2.3.5 Implementation of Protease Assays in Alternate SPR Instrument
Our facilities possess two SPR instruments: a GE Biacore X100 and a BI SPR. In
order to verify the reproducibility of these protease detection assays, we performed a
lethal factor protease detection assay by using both instruments. Results from the BI SPR
are shown in figure 2-11. Response signals of the binding steps corresponding to
streptavidin and LF-15 GFP are in good agreement with previous results using the
Biacore X100. Lethal factor protease shows minimal response during it substrate-binding
time.
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Figure 2-11. Lethal factor protease assay III performed in Biosensing Instrument SPR system.
(A-A’) Streptavidin injection. (B-B’) LF-15 GFP injection. (C-C’) Lethal Factor protease
injection. In order to corroborate the reproducibility of the results from the Biacore SPR
instrument, we opted to perform protease assays by using a second SPR instrumentation (BI
SPR).

2.4 Discussion and Conclusions
We have successfully purified protease substrate proteins comprising of three
domains: the biotinylation sequence, the full-length substrate containing the BoNT-LC
cleaving region, and a EGFP domain. While the latter one is often utilized as the
fluorescence reporter domain for a variety of binding assays11, in this case, this region
contributed to the amount of mass to be cleaved upon protease activity.
We have successfully developed SPR sensor chips for streptavidin attachment. These
chips were surface-treated by chemisorption of biotinylated alkyl thiols on gold-covered
glass films, forming monolayers. Furthermore, these sensor chips haven been effectively
tested by performing binding assays via biotin-streptavidin-biotin building blocks. Such
experiments provided useful information on the binding capacities of the SPR sensor
22

chips by calculating the amount of mass bound to their surface by measuring the angle of
maximum plasmon resonance, represented by response units (RU). We have reported
such binding activity by using two types of SPR instruments: Biacore X100 and BI SPR.
Both systems present similar binding response curves up to the point of injection of the
protease substrate. We conclude that both the Biacore X100 SPR system and the BI-2000
SPR system are suitable devices for our studies. This is supported by binding curves
generated by these instruments showing similar streptavidin and SNAP-25 adsorption
profiles. However the Biacore X100 SPR system is more time efficient at reaching
equilibrium before and after every injection, thus reducing background noise and
providing stability throughout the experiments. In chapter 5 we will further discuss and
propose methods to improve these protease activity assays.
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Chapter 3
Packed-bed Microfluidic Devices for Protease Analysis
3.1 Introduction
3.1.1 Packed Bed Microfluidics in Biotechnology

In this chapter, we describe a simple method of protease detection via
fluorescence-based techniques on microspheres sequestered inside of packed bed
microfluidic channels. Microfluidic devices have significantly contributed to the area of
biomolecular analysis1, and continue to present new technologies2. In general, these
systems are capable of performing at microliter to submicroliter volumetric regimes,
therefore providing a viable alternative for the field of diagnostics in critical regions of
the world where water treatment is a major concern. The design of such devices allow for
fluid samples to be delivered and analyzed at laminar flow regimes, which allows one to
address simple molecular diffusion constrains inherited by solution-based assays. The
implementation of microspheres coupled with the development of packed bed regions
inside the microchannels provides a surface area of analysis capable of molecular
detection while keeping the overall cost for device fabrication low. Given the limitations
observed when using gold chips bearing SAMs as SPR-based sensors, we turned our
focus to the elaboration of these new platforms for protease assays development while
simplifying the biomolecular detection process. Our objective in this section was to
fabricate robust packed bed microfluidic devices capable of housing microspheres and
biomolecular components used in protease detection. We introduced this method for the
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first time to ongoing efforts of BoNTs protease analysis in for disease prevention. This
was inspired by previous successful reports on quantitative and qualitative real-time
studies in a broad range of applications such as bioaffinity assays, multianalyte
detection,3 and immobilization of metabolically active cells.4
The sensing methods described in this chapter are conformed by streptavidinbearing polystyrene microspheres utilized in order to immobilize the biotinylated
substrate SNAP-25 GFP that whose purification process was described in chapter 2. The
importance of these studies is determined by the ability to effectively detect protease
activity at the surface of the beads within the microchannel, as well as by the detection of
protease cleavage of the substrate upon protease injection. We utilized fluorescence
microscopy techniques incorporating the appropriate optics arrangement for GFP
excitation and emission. The binding assays presented in this work are ultimately directed
to explore loss of fluorescence detection techniques recognizing the cleaving effect by
BoNTA/LC protease on its substrate therefore releasing the cleaved GFP-bound region
away from the point of detection.

3.1.2 Protease Assays Inside Packed Bed Microfluidic Devices
After the successful fabrication of these devices and with the additional information
acquired from reports on microsphere-based BoNT protease assays5, we hypothesized
that under laminar flow conditions, these protease-substrate interactions could be
effectively detected by utilizing packed microspheres as sensing surfaces. Hence, it was
expected that, with the aid of fluorescence microscopy, one could monitor the enzymatic
reaction time by using imaging techniques. For example, this method provides feasibility
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at recording images of packed beads with the SNAP-25 GFP substrate complex attached
to their surfaces and compare that with subsequent images that present the loss of
fluoresce due to protease cleavage over time. In addition, given the microchannel design
presented in this study, we were able to detect loss of fluorescence at the surface of the
entrapped microspheres and to quantify the amount of substrate cleaved by the protease
by collecting the cleaved GFP-bound substrate region at the microchannel’s outlet.

3.2 Materials and Methods
3.2.1 Fabrication of Microfluidic Channels
Microfluidic devices were fabricated using standard photolithographic and soft
lithographic techniques.6 In order to hold the beads in place, PDMS-based dams were
incorporated to the fabrication design. Test grade N-type silicon wafers (WaferNet, San
Jose, CA) were treated and developed into master molds for microchannel patterns. First,
they were cleaned with piranha solution for 1 hour, rinsed with DI water and ethanol, and
dried by a stream of N2. In order to create the dam at each channel, we applied two types
of negative photoresists onto the silicon wafers and followed the manufacturer’s
processing guidelines. (See http://microchem.com for further information). Photoresist
SU-8 2010 (MicroChem, Newton, MA) was used to spin-coat a layer of 10 µm in
thickness. Second, a piece of Scotch tape of 0.8 to 1 mm wide was placed across the
wafer. Third, SU-8 2075 (MicroChem, Newton, MA) was used to form a thicker layer of
75 µm. Upon soft baking, the tape was removed thus also removing the thicker
photoresist layer underneath the tape. The microchannel-patterned mask was obtained
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from CAD/Art Services, Bandon, OR. Once it was properly aligned with the photoresistcoated wafer, the sample was exposed to UV radiation.
The elastomeric polymer PDMS was used to form the microchannels as it crosslinked on the master mold. The time necessary to obtain a fully polymerized material was
directly proportional to the temperature of sample incubation. Incubation temperatures
varied from room temperature to 40o C. Then, cross-linked PDMS material was carefully
removed from the master mold. The prepared PDMS channels were irreversibly sealed on
to glass slides using an Ar plasma cleaner. This resulted in microfluidic channels 250 µm
in width, 2.5 cm in length, and 10 µm in height at the dam, and 85 µm in height
elsewhere.

Figure 3-1. Microfabrication process and assembly steps for microchannel fabrication. Channel
patterns including narrowing (dam) in the middle of the channel were developed by applying
standard photolithography techniques on silicon wafers. Small dams were created for the packing
of streptavidin coated-microspheres incubated with SNAP-25 GFP prior to microchannel
packing. Once the device was finalized, channel dimensions consisted of 45 mm in length, 250
µm in width, and 80 µm in height. Height at the narrowing region (dam) is 10 µm.
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Finally, silicone tubes (Cole-Parmer, Vernon Hills, IL) of approximately 1 mm in
inner diameter were cut at the same length and sealed into small perforations made on the
PDMS channels to be used as inlets and outlets, see Figure 3-2.

A	
  

B	
  

Figure 3-2. Finished packed-bed microfluidic channel for protease activity detection. (A) The
device consists of a PDMS support sealed to a glass slide and additional PDMS and silicon tubing
fittings. (B) Photograph of a single channel microfluidic device ready for analysis. Inlet (left) was
connected to a plastic syringe containing loading buffer and pushed with the aid of a syringe
pump. The outlet (right) was directed to a waste container.

3.2.2 Preparation of Biosensing Particles
22 µm Streptavidin-coated polystyrene microspheres were obtained from Spherotec,
Inc. The beads were washed 3 times with DI water and their concentration was of 6.02 X
106 particles/ml, calculated with a Coulter Counter. The beads were resuspended in
protease buffer (50 mM HEPES, 100 mM NaCl, 1mg/ml BSA, 0.025% (v/v) Tween 20,
pH 7.4) in Eppendorf tubes. Subsequently, biotinylated substrate SNAP-25 GFP was
added to the mixing Eppendorf tubes at different concentrations. The samples were
incubated for 1 hr. in order to allow the biotinylated substrate to bind to the streptavidincoated microspheres.
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Figure 3-3. Protease substrate binding to streptavidin beads. Commercial streptavidin polystyrene
beads were used for the attachment of biotinylated SNAP-25 GFP protease substrate in
fluorescence-based assays.

3.2.3 Packing of Beads in Microchannels and Protease Injection
The device was attached to a syringe mounted on a Nexus 3000 syringe pump
(Chemyx, Stafford, TX) in order to inject buffer or samples at a determined flow rate.
Protease buffer was introduced to the microchannels in order to wet the walls and achieve
a stable flow rate. Then, aliquots of 5 µL of the microspheres were introduced to the
channels with a pipette tip. The channels were packed by a layer of microspheres of at
least 1 mm in length. Protease buffer flow was redirected to the channels so that they
were kept wet. Upon flow stabilization, 10 µL of 10nM to 30 nM light chain protease was
injected to the device by using a 10 µL Hamilton syringe and partially perforating the
inlet silicone tubing. The interactions between the protease and the substrate loaded on
the beads were monitored using a Zeiss Axio Imager A2 (Carl Zeiss Microscopy,
Thornwood, NY) fluorescence microscope as the fluorescence signal of the GFP-covered
beads changed upon cleavage of the substrate. Fluorescence experiments were performed
using a blue light as the excitation source for GFP and a 520 nm band pass filter
(Thorlabs, Newton, NJ) for emission detection. Such interactions were recorded over
time by photo and video, using a CCD camera (Andor Technology, Belfast, UK).
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A second set of experiments consisted of preparing two different bead samples.
Sample 1 contained the beads incubated with the substrate as previously described. The
second sample consisted of mixing the already prepared SNAP-25 GFP coated
microspheres as in sample 1 with the addition of the BoNTA/LC directly to the
Eppendorf tubes and incubated for 30 minutes. Then, samples 1 was introduced and
packed in the microchannel. After achieving a significant amount of beads trapped at the
dam, we introduced sample 2 which contained already cleaved substrates bound to the
beads. Then, we compared the two different bead populations (uncleaved vs. cleaved
substrate) by using the CCD camera’s imaging capabilities. This was done in order to test
the limits of detection of to protease-substrate interactions happening inside the
microchannels and those occurring inside a mixing tube prior to loading them inside the
microchannels.

3.3 Results
3.3.1 Qualitative Protease Activity Experiments
Two different qualitative experiments were performed in order to detect the
protease activity of BoNTA/LC. The first one consisted in packing the prepared
microspheres containing SNAP-25 GFP at the microchannel’s dam and then injecting the
BoNTA/LC protease. After injection, we monitored changes of fluorescence at the
packed bed region with pictures at 10-minute intervals. The most significant change in
fluorescence was observed after one hour of protease injection. Possible photobleaching
issues were addressed by performing the same packing process in the absence of the
protease and monitoring fluorescence changes over the same period of time. According to
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the pictures from figure 3-5, fluorescence emitted from the beads remained constant as
time progressed.

B#

A#

100#μm#

100#μm#

Figure 3-4. Protease assay imaging A) False color image of packed streptavidin beads bound to
SNAP-25 GFP. 1 hour mixing was done prior to loading the device with beads. B) Decrease in
GFP fluorescence intensity due to BoNTA/LC protease addition. The image was taken 1 hour
after introducing the protease to the channel via Hamilton Syringe injection.
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Figure 3-5. Photobleaching control. Packed streptavidin beads bound to SNAP-25 GFP were
imaged in the absence of the protease at a constant flow rate. Fluorescence intensity from the
beads was monitored for 1 hour.

Our second experimental procedure was driven by the need to compare the protease
effect when mixed with the substrate-bound microspheres in mixing tubes with the effect
when the components are mixed inside the microchannels. Therefore, we prepared two
different samples containing the beads conjugated with the SNAP-25 GFP substrate
complex after 1 hour of incubation. While the first sample was left unmodified, we added
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the BoNTA/LC protease to the second sample for 30 additional minutes of incubation.
The samples were introduced as described in figure 3-5. We observed that while the
mixing times in both scenarios, protease molecular diffusion was faster when mixing
occurred in mixing micro centrifuge tubes than when inside the microchannels.
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Figure 3-6. Packing process of cleaved and uncleaved substrate bound to beads. This comparison
analysis was done in order to find the limitations of the device in protease assay performance.
Tube 1: Mixed 22 µm Streptavidin polystyrene beads with 500 nM biotin-SNAP25GFP for 1
hour Tube 2: Mixed 22 µm Streptavidin polystyrene beads with 500 nM biotin-SNAP25GFP for
1 hour, then added 10 nM BoNTA/LC protease and mixed for 30 minutes.

3.3.2 Quantitative Protease Activity Experiments
It was also of importance to corroborate the qualitative studies by quantitatively
determining the protease activity. Thus, we calculated the fluorescence decrease as a
result of the protease acting upon the SNAP-25 GFP substrate complex by monitoring the
amount of cleaved fluorescent mass at the device’s outlet. By using a fluorimeter that is
equipped with high sensitivity capabilities we intended to decrease the time of protease
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recognition (it took 45 minutes to 1 hour to observe fluorescence decrease due to
cleavage by using fluorescence microscopy). According to our protease assay design, the
substrate region that was cleaved due to the BoNTA/LC protease was expected to detach
from the microspheres and freely travel in flowing buffer towards the device’s outlet.
Thus, samples were collected from a reservoir connected to the outlet and examined by
using a PTI QuantaMaster 30 Spectrofluorimeter (Photon Technology International,
Birmingham, NJ). Thus, this allowed us to build a correlation between such fluorescence
gain indicating the presence of cleaved GFP-bound substrate released to the collecting
reservoir and the amount of fluorescence lost at the surface of the packed beads. The
curve corresponding to 30 minutes after injection presents a higher peak than that
corresponding to 10 minutes after injection. This was another proof of slow diffusion
rates in which the longer the protease was allowed to be in contact with the beads, the
higher the substrate cleavage was observed. The curve corresponding to buffer flow
without protease also exhibited a peak at the GFP’s emission peak of 507 nm. This can be
explained by the presence of unbound SNAP-25 GFP molecules introduced along with
the conjugated beads that mixed with the flowing buffer and were eventually carried
away from the dam.
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Figure 3-7. Fluorimetric analysis of cleaved SNAP-25 GFP substrate. Samples were collected in
a reservoir after they exited the microfluidic device. All samples were diluted with buffer to reach
500 uL for proper analysis using fluorimeter cuvettes via emission wavelength scanning. Blue:
Buffer (50mM HEPES, 100 mM NaCl) used prior to injection into microfluidic device. Red:
Flowing buffer collected after 30 minutes of flow through packed microspheres covered by
SNAP-25 GFP. Yellow: Collection of cleaved GFP-bound substrate after 10 minutes of
BoNTA/LC exposure. Green: Collection of cleaved GFP-bound substrate after 30 minutes of
BoNTA/LC exposure.

3.4 Discussion and Conclusions
3.4.1 Fabrication of Packed Bed Microfluidic Channels
We have been able to successfully fabricate packed bed microchannel devices
capable of effectively sequestering bio-conjugated microspheres of diameter sizes above
10 µm. These devices have therefore allowed us to design, test, and study BoNTA/LC
protease-substrate interactions. Furthermore, the usefulness of these devices are not
limited to these biological components but rather, they present a potential bioanalytical
tool for a great variety of applications.4,

7

We have demonstrated that our devices
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fabricated in our laboratory can be successfully utilized in those areas. In addition, the
devices fabricated in our laboratory were capable of sustaining increasing flow rates that
reached 80 µL/min, which was sufficient for the regimes delineated by our studies (i.e. 12 µL/min in order to speed up protease diffusion). Finally, we have accomplished to
design a simple method for biomolecular detection. Other important features of this
approach also include portability, low consumption of analyte volume, and low cost in
process fabrication.

3.4.2 Protease Activity Assays
We have been able to monitor BoNTA/LC proteolytic activity by using
qualitatively methods involving monitoring fluorescence changes with the aid
fluorescence microscopy and imaging techniques. We were able to find a correlation
between these findings and those from our designed quantitative methods utilizing
fluorimetric techniques. Fluorescence decrease at the surface of the packed microspheres
was noticeable after 1 hour of protease injection; which was done by taking photographs
every 5 minutes under constant flowing buffer conditions (see figure 3-4). In contrast,
from our quantitative experiments (see figure 3-7), we were able to observe that after 10
minutes upon protease release, fluorescence from cleaved SNAP-25 GFP molecules were
already present at the end of the device’s microchannel. Some of the disadvantages that
we encountered involved transport limitations in the fluid flow of samples. Back pressure
was originated due to the expansion of the PDMS-based microfluidic walls. This was an
issue that was triggered by the microsphere conglomeration at the channel’s dam. Also,
we observed PDMS shards created at the dam region and at both ends due to the
punching effect done to build the channels’ inlets and outlets. These issues triggered
36

limited device functionality for our desired protease assays. The observed slow reaction
times as shown in figure 3-4 can be attributed to these limitations. This lead to device
reproducibility issues which triggered a variation in the fluid flow rate, in spite of setting
our syringe pump at a constant flow rate throughout the experimentation process.
Diffusion limitations may also be attributed to the dimensions of the microchannels,
whose volume comprising of the inlet to the interrogation region was approximately 0.3
µL.
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Chapter 4
Biomimetic Platforms for Protease Diagnostics
4.1 Introduction
4.1.1 SNARE Proteins and their Role in Neurotransmitter Release
In this chapter we study protease sensing methods while emphasizing the biological
role of the SNARE protein complex in neurotransmitter release and hence, in neuron-tomuscle cell communication1,2. This information is crucial for the process of better
understanding the interactions between the BoNT/LC proteases and their substrate
counterparts. Studies suggest that the binding capability of SNAP-25 to cell membranes
is thanks to its four-cysteine residues3. SNAP-25 associates with membranes by
undergoing the process of palmitoylation4. This natural process has been a key element
for the design biomimetic systems capable of being utilized in the development of
protease detection assays. Hence, here we provide information on how to recreate SNAP25 GFP palmitoylation given proposed biomimetic systems consisting of supported lipid
bilayers (SLBs) formed on silica microspheres. Our results will lead to clearer pathways
for the implementation of the other two SNARE complex proteins: syntaxin, and vesicleassociated membrane protein (VAMP) in protease assays by incorporating multiplex flow
cytometry in our studies. This will allow us to conjugate three types of microspheres
varying in size with the three different SNARE proteins and therefore simultaneously
analyze the different bead populations. These efforts will be important contributing
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factors with ongoing research towards understanding the role of SNARE protein complex
in synaptic vesicle fusion5, 6, 7, and in disease triggered by foreign proteolytic activity 8, 9.
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Figure 4-1. Representation of the neuromuscular junction and components of interest. A) Role of
SNARE proteins in neurotransmitter Acetyl Choline release. SNARE proteins: Syntaxin,
Synaptobrevin, Synaptosomal-associated protein 25kDa (SNAP-25) mediate docking and fusion
between the synaptic vesicles and the plasma membrane of the neuron, ultimately allowing
muscle stimulation. These proteins are affected when the host contracts botulism disease. B)
BoNT light chain proteases selectively cleave the SNARE proteins thus preventing acetylcholine
release and causing paralysis and death.
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4.1.2 Supported Lipid Bilayers on Microspheres in Bioanalytical Applications
Supported lipid bilayers (SLBs) are formed by the interactions of two layers of
amphiphilic phospholipids, where their hydrophobic tails are oriented inwards facing one
another, and their hydrophilic heads are oriented outwards. Due to this spontaneous
configuration,10 and their ability to mimic the structure of biological membranes, SLBs
on microspheres have been used extensively in the area of biosensing.11 In addition, a
wide variety of membrane proteins can be incorporated to SLB-microsphere structures
through different anchoring methods. Because of this, and from the information gathered
in section 4.1.1, we introduced the SLB-bead configuration into our protease sensing
studies. The immobilization of SNARE proteins on functionalized lipid bilayers creates
an attractive bioanalytical method for the development of protease assays. Furthermore,
the incorporation of microspheres to the analytical carrying platform allows one to utilize
flow cytometry as an analytical tool for fluorescence-based biomolecular detection. Flow
cytometry is a powerful tool that measures fluorescence intensity bound to every
microsphere, and neglects free fluorescence from solution surrounding the microspheres.
In conventional flow cytometry, microspheres are focused via hydrodynamic focusing in
such a way that they travel down in the flow cell in single file. Thus, this technique
becomes advantageous for purposes of performing real-time protease assays, an
important feature that has been emphasized throughout this thesis. In addition, one
disadvantage of SAMs and streptavidin-coated polystyrene beads as model surfaces is
that they are essentially static. This characteristic differs from that of biological
membranes, which are fluid and rearrange dynamically.
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4.1.3 Biomimetic Protease Detection Platforms for Flow Cytometry
As stated in chapter 1, the natural attachment of SNAP-25 in vivo by reactions
occurring between the protein’s cysteine residues and the synaptic lipid vesicles inside
the neuron. This process is referred to as palmitoylation.12 Located in the peripheral
nervous system, this process plays a central part in the initiation of release of the
neurotransmitter acetylcholine to the exterior of the neuron, which subsequently allows
acetylcholine molecules to bind to their specific receptors bound to the plasma membrane
of muscle cells. The main function of this type of neuron-to-muscle cell chemical
communication is to allow normal contraction of skeletal and smooth muscles.
As a result, our protease assay developmental process will be enhanced and will
provide a pathway for the design of biomimetic protease detection platforms. In order to
mimic natural conditions and obtain relevant information from such conditions we
constructed supported lipid bilayers on porous silica microspheres. We hypothesized that
by utilizing supported lipid bilayers consisting of a small molar fraction of thiolcontaining functionalized lipids we would be capable of specifically building disulfide
bridges between the substrate protein complex (i.e. natural tetra cysteine motif found in
SNAP-25) and the existing thiols from the lipo-microsphere structure. Furthermore, we
would be able to demonstrate the enhancement of our protease assay development due to
our design being a biomimetic arrangement of the natural palmitoylation phenomena
shown in figure 4-1. Because of this, these studies would present advancing results
favoring further understanding of the proteolytic interactions involving BoNTA/LC
proteases and SNARE substrates.
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Figure 4-2. Disulfide bond formation between cysteine residues from SNAP-25 and thiolated
SLBs. Silica beads covered by supported lipid bilayers are formed by spontaneous vesicle fusion.
One can form lipid platforms of one or more types of lipids depending on the application of
interest. Here, phosphatidylcholine lipids are mixed with smaller molar fractions of
phosphothioethanol lipid in order to form disulfide bridges with cysteine residues from SNAP-25.

4.2 Materials and Methods
4.2.1 Surface Treatment of Silica Microspheres
Mesoporous silica beads with 5 nm in pore size and 5 µm in diameter were obtained
from Macherey-Nagel (Duren, Germany). In order to obtain clean, hydrophilic bead
surfaces, treatment processes were applied as previously described.13 Briefly, beads were
washed with ethanol and then DI water several times, respectively. Then they were
suspended in a 40 mL solution containing freshly mixed 4% H2O2 and 4% NH4OH and
placed in an 80° C water bath for 10 min. After several DI water rinses, this was followed
by a second treatment in 40 mL freshly made solution of H2O2 and 0.4 M HCl in the 80
°C water bath for 10 min. After additional DI water rinses, the beads were resuspended in
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20 mL Tris buffer (100 mM Tris, 150 mM NaCl, pH 7.4). A Coulter Counter was then
used to calculate the number of beads per volume.

4.2.2 Preparation of Supported Lipid Bilayers
All lipids were purchased from Avanti Polar Lipids (Alabaster, AL). Small
unilamellar

vesicles

were

prepared

from

1mM

solutions

of

either

egg

phosphatidylcholine (egg PC) or 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) in chloroform, in clean glass vials. In addition, 1,2-dihexadecanoyl-sn-glycero-3phosphothioethanol (PTE), and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[3-(2pyridyldithio)propionate] (PDP-PE), were also used in specific experiments, as described
below. A variety of lipid concentrations were used including 1 mol %, 2 mol %, 5 mol %,
and 10 mol % of PTE or PDP-PE mixed with the remaining egg PC or POPC lipid.
Hamilton syringes were used for lipid and chloroform handling and mixing at all times.
Lipid solutions were then dried under a N2 stream in order to remove the chloroform
and subsequently resuspended in Tris buffer and mixed for 1hr. The samples were then
sonicated on water bath for 30 min and then transported to microfuge tubes to be mixed
with the surface-treated silica beads. The mixtures were vortexed vigorously for 5 min
and then shaken for 25 min at 37 C°. This process allowed the lipid vesicles to
spontaneously form supported lipid bilayers surrounding the beads. Finally, the beads
were washed several times in Tris buffer to eliminate unbound lipids.
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4.2.3 Lipid Stability Analysis

Lipid bilayer stability is a crucial characteristic needed for the success of our
studies, therefore we tested the SLB stability on beads by using Triton detergent as a lipid
bilayer-disrupting agent.14 First, we loaded the surface-treated porous silica beads with 10
mM fluorescein in Tris buffer by constant vortexing for at least 24 hours. After three
washing steps, the beads were coated by lipids at different molar fractions just as
described in section 4.2.2. Fluorescein content was then measured in two different ways.
We monitored fluorescein content entrapped by the SLBs as well as the amount of
fluorescein that leaked towards the aqueous environment outside the membranes. Ideally,
we expected to observe minimum fluorescein leakage for several days until a disrupting
agent was introduced to the system (e.g. Triton X100 surfactant). We monitored direct
fluorescein leakage from the beads using flow cytometry while increase of fluorescein in
solution was measured using spectrofluorimetry. Upon bilayer formation we recorded
fluorescence intensities using both methods every 5 washing steps for a total of 15
washing steps. Stability measurements were recorded following the 15th final wash every
8 hours for several days. In between measurements, the samples were stored at 5OC.
Finally, the non-ionic surfactant Triton X100 was added to the samples and mixed for 30
minutes. Fluorescence measurements were once again recorded in order to monitor
fluorescein leakage due to SLB disruption.
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4.2.4 Biomolecular Assembly and Protease Assays for Flow Cytometry
SNAP-25 solutions were prepared at different concentrations (100 nM to 500 nM)
in Tris buffer. Then, approximately 6.4 X 106 prepared SLB-beads consisting of different
thiol-lipid concentrations ranging from 0 to 10% were added to microfuge tubes, making
a total volume of 500 µL in each tube. The Protein-SLB-beads samples were incubated in
the dark at different times (1 hour to overnight) in order to monitor time-dependent
binding interactions. The samples were analyzed using an Accuri C6 flow cytometer
(Becton-Dickinson, San Jose, CA) and further data analysis was performed using flow
cytometry analysis software such as FlowJo (Tree Star, Ashland, OR) and FCS Express
(De Novo Software, Los Angeles, CA). In order to verify disulfide bridge formation and
specific binding, control experiments consisted in the addition of reducing agents such as
dithiothreitol (DTT) and 2-mercaptoethanol (BME) to the samples, which lead to
fluorescence decrease at the surface of the beads.
BoNTA/LC protease was added to the samples at concentrations ranging from 10
nM to 30 nM, allowing an incubation time of 30 minutes before flow cytometry analysis.

4.3 Results
4.3.1 Lipid Stability Analysis
Three different PTE concentrations mixed with POPC were used to form SLBs in
fluorescein-coated beads for lipid stability studies: 0%, 1%, 2% and 10%. After 15
washing steps following bilayer formation we monitored fluorescence from the beads for
3 days. Minimum fluorescein leakage was observed over this period of time. SLBs
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proved to be able to sequester the majority of the fluorescein molecules surrounding the
beads, thus verifying lipid bilayer stability over time as reported in the literature. As the
concentration of PTE increased, the amount of fluorescein molecules diffusing out of the
SLB-bead complex was higher (see figure 4-3). However, SLBs at all PTE concentrations
are shown to be much more effective at sequestering fluorescein at the surfaces of the
beads than in the case where beads were coated with fluorescein in the absence of SLBs.
Upon reaching the 3-day monitoring final point, we added Triton X100 to the beads in
solution and after 30 minutes of mixing we were able to observe a drastic fluorescence
decrease in all samples. This allowed us to confirm that when a surfactant is present, lipid
bilayers no longer possess their stability property, thus promoting fluorescein leakage
from the surface of the microspheres. As presented in figure 4-3, fluorescence levels from
disrupted SLB-beads were much lower than fluorescein-coated beads without any lipids.
This can be explained, in part, by the result of interactions between a non-ionic surfactant
such as Triton X100 and an organic fluorescent dyes such as fluorescein, causing a shift
to the left in the fluorescein’s emission wavelength maxima.15
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Figure 4-3. Fluorescein-Lipid stability tests using flow cytometry. Binary lipid mixtures of
POPC and PTE at 100%/0%, 99%/1%, and 90%/10% were used respectively. Porous silica beads
were loaded with fluorescein and retained to the bead surface thanks to the formed lipid bilayers
and their stability. After achieving a stable fluorescence reading from all samples after 3 days of
SLB formation (green), we added SLB disrupting surfactant Triton X100 to each sample and
recorded fluorescence change (red). Upon membrane disruption due to the presence of the
surfactant, fluorescein is released triggering a significant loss of fluorescence. In addition, we
compared these measurements to fluorescein loaded to beads in the absence of SLBs (blue).
Fluorescence retention from 90%/10% thiol-SLB mixture was less than half as efficient than the
SLB made out of 100% POPC.

4.3.2 Biomolecular Assembly and Protease Assays for Flow Cytometry
PTE lipids at varying concentrations of 0%, 1%, 2%, and 10% were used for this
part of our studies. The case involving 100% POPC or egg PC was used as a control in
order to address nonspecific binding issues. We looked for binding events other than the
described disulfide formation by mixing non-thiolated SLBs (100% PC, 0% PTE) with
SNAP-25 GFP. According to previous reports on the structural differences between egg
PC and POPC16, egg PC due to its extraction from natural sources, it contains a higher
amount of unsaturated phospholipids than the synthetic POPC17. Therefore, POPC will
form more ordered and more stable SLBs16. This is why we opted to conduct our SLB
experiments with POPC.
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Flow cytometry analysis provided information on fluorescence signals from three
different scenarios: 1) SLBs formed by varying lipid mixtures on microspheres in the
absence of SNAP-25 GFP or any fluorescence marker 2) SNAP-25 GFP added to SLBs
on beads after different mixing times, and 3) BoNTA/LC protease addition to the
previous scenario after 30 minutes of incubation. The first scenario served as a
fluorescence background indicator, i.e. GFP is absent in the mixture. The second scenario
presented a fluorescence increase by approximately 2 decades compared to the initial
scenario when 1%, 2%, and 10% PTE were used. Subsequently, the third scenario
presented a fluorescence decrease by 50% to 60% compared to the second scenario.
However, the control which contained 0% PTE also presented a significant increase in
fluorescence when mixed with SNAP-25 GFP. Featured flow cytometry data in figure 44 and 4-5 compare SNAP-25 GFP binding to thiol-SLB structures and SLBs from purely
POPC after two hours of incubation as well as 7 days after bilayer formation. In these
experiments we intended to prove the binding specificity SNAP-25 to thiols-rich
structures. While SNAP-25 GFP possessed the same molecular availability for it to bind
to both SLB structures, fluorescence signals from beads bearing thiol-SLBs presented a
significant increase over its POPC SLBs counterpart (1.25x106 compared to 2.34 x 105).
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Figure 4-4. Flow cytometry test for specificity of SNAP-25 attachment to thiolated SLBs.
Samples were incubated for 2 hours before analysis. Black: 100% POPC mixed with 800 nM
SNAP-25 GFP. Red: 98% POPC and 2% PTE mixed with 800 nM SNAP-25 GFP. Fluorescence
intensity readings from thiol-containing SLB-beads presented 70% higher fluorescence intensity
than SLBs composed of POPC only (no thiol-lipids).

530/30%Emission%Fluorescence%
Figure 4-5 SNAP-25 GFP binding test comparison after 7 days of SLB formation. Black: SLBs
containing 100% POPC. Red: 98% POPC and 2% PTE. Fluorescence intensity from the
experimental group (red) reached 1.25x106 fluorescence units, while fluorescence intensity from
the control group (black) was of 2.34x105 fluorescence units, which is 80% less than that of the
experimental group.
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In order to quantify non-specific interactions originated by the binding of SNAP-25
with POPC lipid membranes, we utilized DTT to act as a selective reducing agent
targeting the disulfide bridges formed by SNAP-25 GFP and thiol-rich SLB-beads.
Therefore, this compound triggered fluorescence loss at the surface of the beads due to
the detachment of SNAP-25 from the complex. The amount of fluorescence signal lost

Count%

because of the presence of DTT was considered to be associated to specific interactions.

530/30%Emission%Fluorescence%

Figure 4-6. Reduction of 100% POPC SLBs using DTT. Blue: 100% POPC SLBs on beads
without SNAP-25 GFP. Black: 800 nM SNAP-25 GFP bound to 100% POPC SLB beads. Red:
Effect of 100 mM DTT after 30 min. mixing with SNAP-25 bearing SLB-beads.

After conducting several experiments involving DTT at varying concentrations, we
observed that the addition of 100 mM DTT to the beads caused a fluorescence intensity
decrease of 30% to 40%, indicating a considerable amount of non-specific adsorption.
DTT incubation time with SNAP-25-bound beads was 2. Finally, we report a BoNTA/LC
protease activity assay using thiol-SLBs on beads (figure 4-8) in which the protease
shows a certain degree of activity by observing a 58% fluorescence decrease due to
presumed cleavage.
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Figure 4-7. Reduction of 98% POPC and 2% PTE SLBs on beads using DTT. Blue: 98% POPC
and 2% PTE SLBs on beads without SNAP-25 GFP. Black: 800 nM SNAP-25 GFP bound to
thiolated SLBs on beads. Red: Effect of 100 mM DTT after 30 min. mixing with SNAP-25
bearing thiol-SLB-beads.
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Figure 4-8. BoNTA/LC protease assay on PTE/POPC SLBs on beads. Black SNAP-25 GFP
binding to 99% POPC/1% PTE SLBs on beads. Red: BoNTA/LC protease mixed with substrate
sample in solution for 30 min. prior to flow cytometry analysis. Fluorescence intensity decreased
by 58% after apparent cleavage of SNAP-25 GFP substrate.

52

4.4 Discussion and Conclusions
4.4.1 Supported Lipid Stability

We have successfully developed stable and functional supported lipid bilayers on
porous silica microspheres containing binary lipid mixtures selected to promote specific
interactions with our proteins of involved in our studies. Lipid bilayer stability tests
indicate SLBs on beads are the most stable when prepared with 100% POPC. Based on
fluorescein-based stability tests, as the concentration of PTE (thiol-lipid) increased in the
bilayer structure, the more fluorescein was allowed to exit the lipid membrane, therefore
presenting a less stable SLB structure. Because of these findings, we opted to include
lipid mixtures containing up to 2% PTE in our protease assay studies.

4.4.2 Biomimetic Platforms for Protease Activity Assays
We have developed a biomimetic platform designed to resemble the synaptic
vesicle docking to the SNARE protein SNAP-25. SLBs consisted of a small fraction of
thiol-lipids and a larger one of POPC lipids. PTE concentrations were determined by SLB
stability studies, from which we concluded that optimal PTE concentrations were at 1%
to 2%. SNAP-25 GFP was added to this lipid-bead arrangement at different
concentrations. Our flow cytometry studies allow us to conclude that higher fluorescence
readings are found when using SLBs made from these PTE concentrations in comparison
to SLBs containing 100% POPC. However, from our flow cytometry information, show
significant amount of fluorescence on beads bearing the 100% POPC composition, which
indicates the existence of non-specific binding issues. Therefore, quantified this
parameter by adding reducing agents BME or DTT in order to reduce the SNAP-25
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molecules docked to the thiol-functionalized lipid membranes. Fluorescence intensity
readings from beads after this procedure was considered to be corresponding to SNAP-25
molecules bound to the membranes non-specifically. After applying this method in the
majority of our experiments, fluorescence intensities were reduced by half. This
constraint can be attributed to the hydrophobic regions present in our substrate protein
complex, which is composed of a biotinylation region of approximately 100 amino acids
residues, the SNAP-25 sequence region, and the GFP region. Therefore, this synthetic
component is greater in size than the wild type SNAP-25, which creates a higher chance
for steric hindrance once in contact with the SLB on microspheres.
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Chapter 5
Conclusions and Recommendations for Future Work
5.1 Surface-based Protease Assays for Surface Plasmon Resonance Analysis
5.1.1 Conclusions
In chapter 2 we have demonstrated the binding capabilities of SAMs on gold
substrates for protein immobilization. We have successfully fabricated SPR sensor chips
functionalized with biotinylated thiols for streptavidin immobilization. This approach
provides a simple path for assessment of a variety of bioassays. The nature of the
streptavidin/biotin interaction high binding constant (Ka ≈ 1013 M-1)1 has proven to be a
robust tool for its capabilities of forming strong molecular building blocks, and for the
study of protein-surface interactions.
We have gained a significant amount of knowledge in microbiological techniques
associated with the process of expression and purification of proteins. Consequently, as
part of the methodology involved for the completion of our studies, we have successfully
expressed and purified the SNAP-25 protein coupled with a biotinylation region and a
GFP region on opposite ends of the protein for streptavidin-binding and fluorescence
recognition, respectively. While SPR allows for label-free detection, we utilized the
additional amino acid sequence in our design in order to maximize the amount of mass
that could be potentially cleaved by proteases of interest, and thus reducing ambiguous
data. Biomolecular assembly of streptavidin and SNAP-25 GFP onto the surface of our
fabricated SPR sensor chips has been presented in binding assays. As expected, binding
of streptavidin to the biotin-rich sensor surface has been demonstrated via SPR by
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observing increase of resonance signal due to injected streptavidin binding to the surface.
Subsequent injection of biotinylated SNAP-25 showed further increase the resonance
signal. Such response signals have been quantified by accounting for the change in
response units given by the instrument upon binding.
After several trials involving proteases introduced to the SPR instrument and placed
in contact with the active sensor surface, resulting signals deviate from our predicted
protease response. While the proteases present binding response signals once in contact
with the exposed substrates, no significant cleavage can be appreciated. This can be
explained by the hindering effect from GFP molecules, preventing efficient contact
between the protease and the substrate. For the case involving BoNTA/LC protease
detection, injected protease association response signals nearly equaled the dissociation
signals, which indicated nonspecific binding to the SNAP-25 GFP substrate complex.
The case involving lethal factor protease detection (figure 2-9) suggests specific binding
response signals in all biological components. Cleavage response is very slow,
nonetheless this is in good agreement with the bead-based protease assays reaction times
reported elsewhere2.
Finally, we conclude that several parameters have be taken into consideration for
their contributions to hinder effective protease assays. These are: SAM organization and
molecular ordering, impurities from recombinant protein extraction procedures, protein
denaturation effects, geometry of sensor surfaces (flat, rectangular surface area as
opposed to previous reports on spherical surfaces), and non-specific binding. We have
demonstrated that SPR-based analytical techniques are valuable for protease kinetics by
providing with real time methods to recognize and segregate the time corresponding
substrate-binding events from that of the proteolytic/cleavage events.
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5.1.2 Recommendations for Future Work
One of the disadvantages from this adopted technique is the reproducibility issue
concerning SPR binding responses. Initial baselines varied significantly, which denotes
varying SAM content at the sensor chips. This triggered different SPR response signals
when proteins of interest were introduced to the system. Previously reported studies3
indicate that SAMs formed by biotinylated thiols are disordered and their headgroups do
not show specific orientation, thus making streptavidin immobilization less efficient by
contributing to non-specific interactions. A proposed solution for more order biotinylated
SAMS has also been published3 and it consists of SAMs formed by binary thiol mixtures
incorporating a second shorter hydrophobic thiol. This arrangement promotes closely
packed, more organized SAMs. Determining optimal molar fractions of the thiols in
question require further analysis and more complexity. Using X-ray photoelectron
spectroscopy (XPS) allows one to build a correlation between the surface composition of
the SAM and the mole fractions in solution4.
An additional alternative for enhancing surface sensor chip design is the
implementation of SAMs terminated with a nitrilotriacetic acid (NTA) group, which is
known to forms a tetravalent chelate with Ni (II)5. This approach is to be coupled with
proteins of interest that contain a termination of commonly six histidines in their
sequence. Therefore, recombinant his-tagged SNAP-25 GFP and LF-15 substrates could
specifically bind to SPR sensor chips rich in NTA-SAMs, reducing the longer peptide
sequence presented in this work (biotinylation sequence), thus minimizing the amount of
non-specific adsorption.
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5.2 Packed-bed Microfluidic Devices for Protease Analysis
5.2.1 Conclusions
The Packed-bed microfluidic channel approach is a biosensing technique that can
be adopted for a variety of bioanalytical assays. Our devices presented ease in portability
and great efficiency at sample and buffer consumption. They were inexpensive to
fabricate and allowed us to design multiple channels on one chip for the analysis of
different compounds and controls. We have demonstrated, as presented in figure 3-4 and
figure 3-7, simple qualitative and quantitative methods for protease detection via
fluorescence microscopy and fluorimetry, respectively. However, we encountered several
constraints that need to be addressed in order to improve the protease assay process
development. 1) There is a dominance of mass transport over kinetics, which is
reaffirmed by backpressure build up in the channels duo to expansion of the PDMS
microfluidic walls. 2) The devices presented reproducibility issues due to the nature of
their fabrication process. While we reduced the cost of the micro-fabrication process, we
were limited to roughly 10 µm in channel width and height. This constraint makes them
unsuitable for the packing of microspheres of less than 10 µm in diameter because they
would flow through the dam, towards the channel outlet.
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5.2.2 Recommendations for Future Work
In order to build microfluidic devices at smaller dimensions, capable of analyzing
smaller beads we suggest the implementation of deep reactive-ion etching (DRIE) to the
fabrication process. This cleanroom technique allows for the development of
microchannel sizes lower than 10 µm and greater fidelity than our described
softithographic techniques. This improved approach will reduce channel backpressure by
substituting PDMS for a better precursor material capable of eliminating expansion
effects at the channel’s walls. Hence, microfluidic channel characterization would be
enhanced for the analysis of mass transfer and reaction kinetics parameters6.
We have presented assays based on the loss of fluorescence at the surface of
streptavidin polystyrene beads. Because of this, we have started at a given GFP
fluorescence level indicated by the substrate and finished at reduced fluorescence
intensities due to the cleavage effect by the protease. In addition, further consistency in
fluorescence measurements can be achieved by developing assays based on gain in
fluorescence rather than loss of fluorescence. This can be done by exploring fluorescence
resonance energy transfer (FRET) approaches7, 8. An example of FRET pairs that are
suitable and recommended for these studies include Pacific Blue (exc. ~410 nm, em.
~455 nm) or Alexa 405 (exc. ~402 nm, em. ~421 nm) as the donor component, and GFP
(exc. ~489 nm, em. ~509 nm) as the acceptor component. In this scenario, we would mix
a blue dye-labeled streptavidin with SNAP-25 GFP, such that fluorescence is transferred
from donor molecules to the acceptor molecules. Thus, donor molecules lose
fluorescence while the acceptor SNAP-25 GFP complex gains fluorescence. Once
BoNTA/LC cleavage of the SNAP-25 GFP substrate complex occurs, GFP is freed which
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in turn, terminates FRET. In this manner, we would be able to monitor gain in
fluorescence at the donor’s side and as a result, analyze the BoNTA/LC activity.

5.3 Biomimetic Platforms for Protease Diagnostics
5.3.1 Conclusions
We have successfully developed fluidic membranes on microspheres capable of
sustaining biological compounds and of carrying reactions at the surface of beads.
Phospholipid membrane contents were formed to mimic natural membranes found in
neurons whose role is to promote synaptic vesicle fusion (palmitoylation). Specifically,
we have studied supported lipid bilayers containing PTE lipids or PDP-PE lipids. The
first one consists of thiolated headgroups, and the second one contains pyridyldithiol
groups (disulfide). They were both studied in SLBs while mixed with more abundant
POPC or Egg PC lipids. We intended to recreate the binding process of palmitoylation
between these membranes and recombinant SNARE protein SNAP-25 GFP. We believe
that specific binding in the form of disulfide bridges between SNAP-25’s cysteine’s
thiols and thiol-rich SLBs were formed when using molar percentages of 1%, 2% and 5%
PDP-PE or PTE. We were able to discriminate between specific and non-specific binding
events by utilizing DTT as a membrane disrupting agent in our experiments by reducing
these complexes at their disulfide bridges and thus, attributing the rest of membranebound protein to non-specific interactions. We believe non-specificity was considerably
high due to the additional amino acid residues present in our recombinant protease
substrate. 1) Part of this issue is due to the presence of cysteines in GFP’s amino acid
sequence, which can be seen at http://www.uniprot.org/blast/?about=P42212[1-238]. 2)
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This issue can also be explained by the presence of possible impurities in SNAP-25
originated by the protein’s expression and purification process. 3) Amino terminal
biotinylation tags of approximately 100 amino acid residues may also have provided nonspecific SNAP-25 binding sites.
Flow cytometric BoNTA/LC protease assays performed using described SLBs have
proved to present active substrate cleavage by observing fluorescence reduction of 60%
on SNAP-25 GFP-bearing microspheres. These results are promising and provide room
for improvement, which include appropriate and timely handling of all proteases and
substrate proteins, and reduction of non-specific binding between protease substrates and
membranes. Flow cytometry has proven to be a time-efficient, simple to operate, and
overall, a more robust technique for our desired protease assays than techniques
described in pervious chapters.

5.3.2 Recommendations for Future Work
Given the advantages that flow cytometry provides to our protease assay
development process, one will be able to conduct protease assays involving all SNARE
proteins bound to microspheres simultaneously. Furthermore, as stated previously, there
are ongoing research efforts in the area of high throughput screening and protease activity
detection of all BoNT protease types involved in disease9,

10, 11

. Our methods and

findings provide meaningful contributions to these areas and at a greater degree if we
improve the design of biomimetic surfaces capable binding with SNAP-25 in a specific
manner. High throughput screening and multiplexing efforts currently feature static
biomolecular conjugations and interactions. Our studies would enhance these areas of
studies thanks to the fluidity and stability presented by SLBs.
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In addition, we propose the application of histidines/Ni-NTA complex formation
approaches in our flow cytometry studies. Vector plasmids for recombinant His-tagged
proteins can be easily obtained from a variety of commercial sources. Coupling studies of
His-tagged proteins to biomimetic membranes is a subject of ongoing research in our
laboratory.

SNARE&Protein&

Figure 5-1. Recombinant SNARE protein with six terminal histidines binds to Ni-NTA
functionalized SLBs on microspheres. These proteins can be easily purified by known
chromatography techniques, yielding His-tagged and GFP-tagged proteins with high efficiency.
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